Pluripotent stem cell-derived CTLs targeting FGFR3-TACC3 fusion gene in osteosarcoma.
Zhan H, Xiao J, Shi S, Zou F, Wang S, Mo F, Liu X, Zhang B, Dai M, Zeng J, Liu H.
Zhan H, et al. Among authors: shi s.
Int Immunopharmacol. 2024 Sep 21;142(Pt B):112862. doi: 10.1016/j.intimp.2024.112862. Online ahead of print.
Int Immunopharmacol. 2024.
PMID: 39306889